Comparison of short-course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation.


Journal

Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688

Informations de publication

Date de publication:
Aug 2022
Historique:
revised: 25 04 2022
received: 04 02 2022
accepted: 12 05 2022
pubmed: 23 5 2022
medline: 13 8 2022
entrez: 22 5 2022
Statut: ppublish

Résumé

Stenosis of the biliary anastomosis predisposes liver graft recipients to bacterial cholangitis. Antibiotic therapy (AT) is performed according to individual clinical judgment, but duration of AT remains unclear. All liver graft recipients with acute cholangitis according to the Tokyo criteria grade 1 and 2 after endoscopic retrograde cholangiography (ERC) were included. Outcome of patients treated with short AT (<7 days) was compared to long AT (>6 days). Recurrent cholangitis (RC) within 28 days was the primary end point. In total, 30 patients were included with a median of 313 (range 34-9849) days after liver transplantation until first proven cholangitis. Among 62 cases in total, 51/62 (82%) were graded as Tokyo-1 and 11/62 (18%) as Tokyo-2. Overall median duration of AT was 6 days (1-14) with 36 cases (58%) receiving short AT and 26 (42%) receiving long AT. RC was observed in 10 (16%) cases, without significant difference in occurrence of RC in short versus long AT cases. CRP and bilirubin were significantly higher in patients with long AT, while low serum albumin and low platelets were associated with risk of RC. A shorter antibiotic course than 7 days shows good results in selected, ERC-treated patients for post-transplantation biliary strictures.

Identifiants

pubmed: 35598281
doi: 10.1111/tid.13868
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13868

Informations de copyright

© 2022 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC.

Références

Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):3-16. https://doi.org/10.1002/jhbp.518
Buis CI, Verdonk RC, Van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 1: radiological features and risk factors for early vs. late presentation. Liver Transpl. 2007;13(5):708-718. https://doi.org/10.1002/lt.21166
Verdonk RC, Buis CI, van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 2: management, outcome, and risk factors for disease progression. Liver Transpl. 2007;13(5):725-732. https://doi.org/10.1002/lt.21165
Larghi A, Tringali A, Rimbaş M, et al. Endoscopic management of benign biliary strictures after liver transplantation. Liver Transpl. 2019;25(2):323-335. https://doi.org/10.1002/lt.25358
Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int. 2011;24(4):379-392. https://doi.org/10.1111/j.1432-2277.2010.01202.x
Miura F, Okamoto K, Takada T, et al. Tokyo guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31-40. https://doi.org/10.1002/jhbp.509
Gomi H, Solomkin JS, Takada T, et al. TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):60-70. https://doi.org/10.1007/s00534-012-0572-0
Doi A, Morimoto T, Iwata K. Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect. 2018;24(11):1184-1189. https://doi.org/10.1016/j.cmi.2018.01.021
Satake M, Yamaguchi Y. Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: a single-center retrospective cohort study. Int J Infect Dis. 2020;96:343-347. https://doi.org/10.1016/j.ijid.2020.04.074
Tinusz B, Szapáry L, Paládi B, et al. Short-course antibiotic treatment is not inferior to a long-course one in acute cholangitis: a systematic review. Dig Dis Sci. 2019;64(2):307-315. https://doi.org/10.1007/s10620-018-5327-6
Ferstl PG, Filmann N, Heilgenthal EM, et al. Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates. PLoS One. 2021;16(1):e0245091. https://doi.org/10.1371/journal.pone.0245091
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
Kogure H, Tsujino T, Yamamoto K, et al. Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage. J Gastroenterol. 2011;46(12):1411-1417. https://doi.org/10.1007/s00535-011-0451-5
van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc. 2002;55(4):518-522. https://doi.org/10.1067/mge.2002.122334
Limmathurotsakul D, Netinatsunton N, Attasaranya S, Ovartlarnporn B. An open-labeled, randomized controlled trial comparing between short duration and standard 14 days antibiotic treatments for acute cholangitis in patients with common bile duct stone afte successful endoscopic biliary drainage. A preliminary report. Gastrointest Endosc. 2014;79:AB251.
Uno S, Hase R, Kobayashi M, et al. Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. Int J Infect Dis. 2017;55:81-85. https://doi.org/10.1016/j.ijid.2016.12.018
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019;43(2):181-193. https://doi.org/10.1002/jpen.1451

Auteurs

Philip G Ferstl (PG)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Alexander Queck (A)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Katharina Bremer (K)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Natalie Filmann (N)

Institute of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt am Main, Germany.

Nina Weiler (N)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Martin-W Welker (MW)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Oliver Waidmann (O)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Mate Knabe (M)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Wolf O Bechstein (WO)

Department for General and Hepatobiliary Surgery, University Hospital, Goethe University, Frankfurt am Main, Germany.

Michael Hogardt (M)

Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.

Volkhard A J Kempf (VAJ)

Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.

Stefan Zeuzem (S)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Jonel Trebicka (J)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Mireen Friedrich-Rust (M)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Dirk Walter (D)

Department for Internal Medicine I/Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH